News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
784,089 Results
Type
Article (66007)
Company Profile (398)
Press Release (717665)
Multimedia
Podcasts (172)
Webinars (26)
Section
Business (213338)
Career Advice (3233)
Deals (37372)
Drug Delivery (147)
Drug Development (87187)
Employer Resources (182)
FDA (18159)
Job Trends (16135)
News (367779)
Policy (37296)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2924)
Academic (1)
Accelerated approval (34)
Adcomms (36)
Allergies (148)
Alliances (54382)
ALS (180)
Alzheimer's disease (1797)
Antibody-drug conjugate (ADC) (348)
Approvals (18343)
Artificial intelligence (590)
Autoimmune disease (165)
Automation (38)
Bankruptcy (388)
Best Places to Work (12184)
BIOSECURE Act (23)
Biosimilars (203)
Biotechnology (261)
Bladder cancer (164)
Brain cancer (64)
Breast cancer (665)
Cancer (5061)
Cardiovascular disease (447)
Career advice (2756)
Career pathing (41)
CAR-T (305)
CDC (59)
Celiac Disease (2)
Cell therapy (820)
Cervical cancer (37)
Clinical research (73812)
Collaboration (1832)
Company closure (4)
Compensation (1166)
Complete response letters (73)
COVID-19 (2973)
CRISPR (99)
C-suite (877)
Cystic fibrosis (155)
Data (6317)
Decentralized trials (2)
Denatured (59)
Depression (152)
Diabetes (531)
Diagnostics (7056)
Digital health (46)
Diversity (13)
Diversity, equity & inclusion (43)
Drug discovery (285)
Drug pricing (225)
Drug shortages (34)
Duchenne muscular dystrophy (241)
Earnings (87967)
Editorial (65)
Employer branding (22)
Employer resources (157)
Events (121716)
Executive appointments (1028)
FDA (21363)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1555)
Gene editing (216)
Generative AI (56)
Gene therapy (667)
GLP-1 (1130)
Government (5248)
Grass and pollen (8)
Guidances (385)
Healthcare (20053)
HIV (62)
Huntington's disease (50)
IgA nephropathy (86)
Immunology and inflammation (296)
Immuno-oncology (62)
Indications (104)
Infectious disease (3261)
Inflammatory bowel disease (205)
Inflation Reduction Act (15)
Influenza (121)
Intellectual property (251)
Interviews (599)
IPO (17342)
IRA (58)
Job creations (4327)
Job search strategy (2258)
JPM (67)
Kidney cancer (16)
Labor market (85)
Layoffs (651)
Leadership (40)
Legal (8957)
Liver cancer (99)
Longevity (15)
Lung cancer (680)
Lymphoma (381)
Machine learning (45)
Management (62)
Manufacturing (850)
MASH (175)
Medical device (14702)
Medtech (14754)
Mergers & acquisitions (21114)
Metabolic disorders (1404)
Multiple sclerosis (164)
NASH (23)
Neurodegenerative disease (355)
Neuropsychiatric disorders (102)
Neuroscience (3130)
Neurotech (1)
NextGen: Class of 2026 (7152)
Non-profit (4951)
Now hiring (56)
Obesity (687)
Opinion (328)
Ovarian cancer (169)
Pain (216)
Pancreatic cancer (234)
Parkinson's disease (303)
Partnered (36)
Patents (512)
Patient recruitment (492)
Peanut (59)
People (63250)
Pharmaceutical (91)
Pharmacy benefit managers (33)
Phase 1 (22961)
Phase 2 (32294)
Phase 3 (24296)
Pipeline (5231)
Policy (337)
Postmarket research (2934)
Preclinical (9950)
Press Release (72)
Prostate cancer (250)
Psychedelics (57)
Radiopharmaceuticals (300)
Rare diseases (926)
Real estate (6660)
Recruiting (75)
Regulatory (27803)
Reports (48)
Research institute (2674)
Resumes & cover letters (515)
Rett syndrome (28)
RNA editing (18)
RSV (84)
Schizophrenia (160)
Series A (260)
Series B (198)
Service/supplier (13)
Sickle cell disease (103)
Special edition (27)
Spinal muscular atrophy (175)
Sponsored (47)
Startups (4035)
State (2)
Stomach cancer (20)
Supply chain (111)
Tariffs (101)
The Weekly (111)
Vaccines (1144)
Venture capital (98)
Weight loss (471)
Women's health (88)
Worklife (22)
Date
Today (18)
Last 7 days (637)
Last 30 days (2455)
Last 365 days (31872)
2026 (3028)
2025 (32280)
2024 (37212)
2023 (42090)
2022 (53364)
2021 (58031)
2020 (56667)
2019 (49617)
2018 (37761)
2017 (35760)
2016 (35814)
2015 (41512)
2014 (34971)
2013 (30165)
2012 (32091)
2011 (32609)
2010 (30857)
Location
Africa (1064)
Alabama (92)
Alaska (6)
Arizona (308)
Arkansas (13)
Asia (47387)
Australia (8008)
California (11487)
Canada (3302)
China (1179)
Colorado (479)
Connecticut (498)
Delaware (345)
Europe (107593)
Florida (1705)
Georgia (367)
Hawaii (4)
Idaho (67)
Illinois (929)
India (67)
Indiana (518)
Iowa (23)
Japan (434)
Kansas (129)
Kentucky (41)
Louisiana (30)
Maine (82)
Maryland (1450)
Massachusetts (8401)
Michigan (349)
Minnesota (652)
Mississippi (6)
Missouri (139)
Montana (34)
Nebraska (29)
Nevada (124)
New Hampshire (85)
New Jersey (3092)
New Mexico (32)
New York (3037)
North Carolina (1575)
North Dakota (10)
Northern California (5551)
Ohio (351)
Oklahoma (23)
Oregon (45)
Pennsylvania (2303)
Puerto Rico (23)
Rhode Island (44)
South America (1446)
South Carolina (67)
South Dakota (1)
Southern California (4465)
Tennessee (173)
Texas (1780)
United States (41236)
Utah (347)
Vermont (1)
Virginia (277)
Washington D.C. (88)
Washington State (954)
West Virginia (4)
Wisconsin (126)
Wyoming (2)
784,089 Results for "u s agency for international development".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development U.S.
January 22, 2026
·
3 min read
In partnership with PII
Bridging Formulation and Device: Integrated Supply Chain Strategies for U.S. Pharma Manufacturing
The pharmaceutical supply chain and device development have become intricately linked. Harmonizing formulation development with drug delivery device design—and leveraging a single‐vendor ecosystem—can deliver significant time, cost, and regulatory advantages for US‑focused drug products, according to industry experts.
December 8, 2025
·
5 min read
·
Jennifer Smith-Parker
Press Releases
Rakuten Medical Raises $100 Million in Oversubscribed Series F to Accelerate Development Toward U.S. Regulatory Approval
January 7, 2026
·
10 min read
Press Releases
PolTREG Establishes U.S. Subsidiary Immuthera to Advance International Development Strategy
June 16, 2025
·
5 min read
Job Trends
Report: U.S. Life Sciences Job Market Report Q4 2025
BioSpace’s 2025 Q4 U.S. Life Sciences Job Market update highlights early signs of stabilization in biopharma hiring, with modest gains in job postings, slowing layoffs, and cautiously improving sentiment heading into 2026.
January 19, 2026
·
1 min read
·
BioSpace Insights
Opinion
Fate of FDA’s Laboratory-Developed Testing Final Rule Hints at
Chevron
Overturn’s Ramifications
In one of the first demonstrations of the impact of last year’s Loper Supreme Court decision on challenges to agency authority, a judge ruled that the FDA does not have authority to regulate tests developed by clinical laboratories.
September 29, 2025
·
4 min read
·
Megan Robertson
Press Releases
FibroBiologics Files IND Application with the U.S. FDA to Advance Clinical Development of CYPS317 in Patients with Psoriasis
January 1, 2026
·
5 min read
Press Releases
Uniphar announces U.S. expansion, integrating leading companies and appointing new senior leadership
- New integration aligns U.S. operations, unifying RRD BioPharma Development, Uniphar Clinical, Diligent Health Solutions and BESTMSLs under the Uniphar brand. - Mike Ebhardt is appointed President of Uniphar Pharma Services U.S., alongside Cindy Thompson as Vice President of Operations and Transformation.
November 3, 2025
·
1 min read
Regulatory
FDA Pauses Denali’s Pompe Plans Due to Preclinical Safety Signals
Hypersensitivity reactions in a mouse model prompted the agency to suspend Denali’s planned Phase I development for DNL952 for Pompe disease.
December 5, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Approval of ZYCUBO® (copper histidinate), the First and Only Approved Treatment for Menkes Disease in the United States
January 13, 2026
·
13 min read
1 of 78,409
Next
